The relapse-free survival period was significantly associated with the expression of tumor immune response-related genes, such as IL1A, molecular identification group (MIG), TCR repertoire clonetype, and HLA-C expression, based on both Pearson_p-value and logrank_p-value (Table 1). The gene discussed is HLA-C; the disease is neoplasm.